绘制转录的基因调节图,以识别与胰腺癌风险相关的功能变异和基因
Xiaoyang Wang1,2, Hui Geng1, Zhengyan Yao1
1Department of Epidemiology and Biostatistics, School of Public Health, Wuhan University, Wuhan, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|March 13, 2026
概括
研究人员发现了一种基因变异rs11102484,可显著降低胰腺癌风险. 这种变异影响ST7L基因表达,为胰腺癌的发展和潜在的治疗点提供了新的见解.
科学领域:
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 胰腺癌是一种高度致命的恶性瘤,具有复杂的遗传基础.
- 全基因组关联研究 (GWAS) 已经确定了许多风险位置,但将非编码变异与特定基因联系起来仍然具有挑战性.
研究的目的:
- 构建一个全基因组的胰腺癌调控图.
- 将表达量特征位置 (eQTL) 数据与GWAS集成,以识别和优先考虑与胰腺癌风险相关的因果变异.
- 为了功能性地表征一种新的风险调节基因变异.
主要方法:
- 在482个胰腺组织上进行表达量的特征位点 (eQTL) 分析.
- 全基因组关联研究 (GWAS) 的元分析.
- 功能性测试包括ZNF263结合,染色素相互作用分析和基因表达研究.
主要成果:
- 确定了82个显著变异和15个与胰腺癌风险相关的基因.
- 在独立队列中验证了rs11102484,显示G等位基因显著降低胰腺癌风险 (OR=0.85).
- 证明rs11102484的保护性G等位基损害了ZNF263结合,导致ST7L表达增加,通过AKT/β-catenin信号抑制癌细胞增殖.
结论:
- 在胰腺癌易感性中涉及的功能基因.
- 描述了一个调节变体 (rs11102484),它调节ST7L表达,为GWAS发现提供了一种机制.
- 提高了对胰腺癌生物学的理解,并通过ST7L调制确定了潜在的治疗标.
更多相关视频
09:52Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
Published on: April 19, 2013
24.9K
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.5K
相关概念视频
Epigenetic Regulation
4.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
4.1K
Epigenetic Regulation
34.2K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.2K
Cancer-Critical Genes I: Proto-oncogenes
11.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K
Cancer-Critical Genes I: Proto-oncogenes
5.9K
5.9K
Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
